Regenerative Stem Cell Procedure News Today : Breaking News, Live Updates & Top Stories | Vimarsana

1.3 - 85% Less Pain The company will seek out locations across the USA geographically dispersed to provide maximum access to potential patients. Patient recruitment will begin immediately upon signing of the first clinical site.  The first 100 patients recruited in the USA will be followed-up with in a similar cadence as showcased above (30 days; 6 months; 12 months) and all data will be entered into a clinical registry and overseen by an independent board in preparation for publication in peer-reviewed journal.      We are excited to bring this life changing procedure to the millions of Americans that experience DDD every year, said Timothy Warbington, President and CEO of Creative Medical Technology Holdings Inc.  We have heard from hundreds of patients through our website (www.stemspine.com) regarding how debilitating lower back pain can be, and we are proud to be the first and only company to deliver a validated autologous, bone marrow derived stem cell based procedu

United statesTimothy warbingtonExchange commissionCreative medical technology holdings incCreative medical technology holdingsPrnewswire creative medical technology holdings incMedical technology holdingsRegenerative stem cell procedureDegenerative disc diseaseThreshold averageUnited states patentSmall capHealth care amp hospitalsMedical pharmaceuticalsஒன்றுபட்டது மாநிலங்களில்பரிமாற்றம் தரகு